Onyx (ONXX) Ticks Lower As Bayer May Target Warner Chilcott Instead
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is trading a little lower in pre-open trading Friday following speculative reports that partner Bayer could target Warner Chilcott plc (Nasdaq: WCRX) in a takeover.
This could suggest to the market that Bayer will not buy Onyx, which has been rumored forever and re-ignited recently after Bayer said it is in the market for a big deal.
WCRX is up 11%, while ONXX is down 2%.
This could suggest to the market that Bayer will not buy Onyx, which has been rumored forever and re-ignited recently after Bayer said it is in the market for a big deal.
WCRX is up 11%, while ONXX is down 2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- CoStar Group acquires Zonda for $800M, adding new home data
- TMCR raises $165M to acquire additional Mesabi iron ore royalty
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
